The fund seeks to achieve its investment objective by primarily investing in a core portfolio of 20 to 35 equity securities comprised of U.S. issuers and issuers of foreign developed markets and/or emerging markets.

ARIA Opportunities ETF

ARIAD Pharmaceuticals, Inc. operates as a global oncology firm, dedicated to the identification, advancement, and commercialization of innovative therapies. Its core mission is to significantly improve the lives of those affected by cancer. Leveraging an innovative methodology grounded in structure-based drug design, the company has successfully pioneered numerous precision-targeted treatments, particularly addressing malignancies that are resistant to existing therapies or are inherently challenging to manage.

ARIA Holdings & Sector Breakdown